1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. IMMATICS N.V
Immatics N.V
XNAS: IMTX

Immatics N.V Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-...

Read More
11.37 0.23 (2.06%)
173.98% Gain from 52W Low
372.5K
XNAS Volume

XNAS 08 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Immatics N.V is on 13 May 2026 for the purpose of Immatics NV First Quarter Earnings Results for 2026 See details
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
14.2 / 100
Momentum Score
Technically Moderately Bullish
60.3 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
19
1Yr Price target upside is 65%
8 analysts

Immatics N.V Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..